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Abstract
Background: Depression is a global health challenge. Prevention is highlighted as a priority to reduce its
prevalence. Although effective preventive interventions exist, the efficacy and coverage can be improved.
One proposed means to increase efficacy is by using interventions to target specific risk factors, such as
rumination. Rumination-focused CBT (RFCBT) was developed to specifically target depressive rumination and
reduces acute depressive symptoms and relapse for patients with residual depression in a randomised
controlled trial. Preliminary findings from a Dutch randomised prevention trial in 251 high-risk 15- to 22-year-old
subjects selected with elevated worry and rumination found that both supported internet-RFBCT and group-delivered
RFCBT equally reduced depressive symptoms and the onset of depressive cases over a period of 1 year, relative to the
no-intervention control.
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Methods/Design: A phase III randomised controlled trial following the Medical Research Council (MRC) Complex
Interventions Framework will extend a Dutch trial to the United Kingdom, with the addition of diagnostic interviews,
primarily to test whether guided internet-RFCBT reduces the onset of depression relative to a no-intervention control.
High-risk young adults (aged 18 to 24 years), selected with elevated worry/rumination and recruited through university
and internet advertisement, will be randomised to receive either guided internet-RFCBT, supported by clinical
psychologists or mental health paraprofessionals, or a no-intervention control. As an adjunct arm, participants are also
randomised to unguided internet-RFCBT self-help to provide an initial test of the feasibility and effect size of this
intervention. While participants are also randomised to unguided internet-RFCBT, the trial was designed and powered
as a phase III trial comparing guided internet-RFCBT versus a no-intervention control. In the comparison between these
two arms, the primary outcomes are as follows: a) onset of major depressive episode over a 12-month period, assessed
with a Structured Clinical Interview for Diagnosis at 3 months (post-intervention), 6 months and 15 months after
randomisation. The following secondary outcomes will be recorded: the incidence of generalized anxiety disorder,
symptoms of depression and anxiety, and levels of worry and rumination, measured at baseline and at the same
follow-up intervals. In relation to the pilot investigation of unguided internet-RFCBT (the adjunct intervention arm), we
will assess the feasibility and acceptability of the data-collection procedures, levels of attrition, effect size and
acceptability of the unguided internet-RFCBT intervention.
Discussion: Widespread implementation is necessary for effective prevention, suggesting that the internet may be a
valuable mode of delivery. Previous research suggests that guided internet-RFCBT reduces incidence rates relative to
controls. We are also interested in developing and evaluating an unguided version to potentially increase the
availability and reduce the costs.
Trial Registration: Current Controlled Trials ISRCTN12683436. Date of registration: 27 October 2014
Keywords: Randomised controlled trial, Cognitive behavioural therapy (CBT), Rumination, Depression, Prevention,
Internet delivery
Background
Depression is one of the leading causes of disease burden
worldwide, with substantial individual, societal and eco-
nomic impact [1]. Current treatments have only a limited
impact on this disease burden because of the lack of treat-
ment availability, the high proportion of patients failing to
respond (40 %, including partial and non-response) and
the high levels of relapse or recurrence (50-80 %) [2]. In
addition, treatments provided in the acute phase of the
disorder do not reduce the incidence rates. Effective
preventive interventions are therefore needed to reduce
the disease burden of depression.
Preventive interventions for depression have mainly
focused on children and adolescents and have predomin-
antly used CBT strategies. Meta-analyses [3–5] have found
that universal interventions (aimed at entire populations,
regardless of risk factors) had only small-to-insignificant
effect sizes post-intervention and longer-term effects were
mixed. Greater effect sizes were found for targeted inter-
ventions (selective: aimed at a subgroup presenting with
known risk factors; indicated: aimed at individuals with
subclinical symptoms), and these effects were sustained
for longer than universal interventions [5]. Critiques of
prevention research trials include a focus on treatment
effects (change in symptoms relative to controls [3]) rather
than on a reduction in incidence rates [6]; insufficient
statistical power due to low base-rates (particularly in
universal samples); and short follow-up periods, which
interfere with the elucidation of longer-term effects [5].
While there are some early positive findings from
prevention research, improvement is possible in terms of
efficacy, cost-effectiveness and acceptability [7]. First, in-
terventions should be targeted at higher-risk individuals
rather than at universal populations [7]. Such individuals
have the most to gain from an intervention, and the base
rate of new cases will be higher in high-risk groups, mean-
ing that smaller sample sizes are needed to obtain
adequate statistical power to detect an effect [6]. Such in-
dividuals could be identified on the basis of personal and
familial history, cognitive or biological vulnerabilities to
depression, and/or subsyndromal symptoms. Risk factors
can be used not only to identify individuals but also as a
direct target for intervention [7]. Additionally, although
current interventions are largely aimed at specific disor-
ders, evidence is increasing for transdiagnostic processes,
which are risk factors for multiple disorders [8, 9]. Target-
ing such processes has the potential to impact several
disorders with a single intervention [10].
Repetitive negative thought (RNT), incorporating worry
and rumination, has been proposed as a potential target
for selective prevention programmes [7]. Strong evidence
exists that RNT contributes to the onset and maintenance
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of a range of disorders, including depression, anxiety and
physical health issues [11]. Prospective longitudinal studies
have found that rumination predicted a) future depressive
symptoms, even after controlling for baseline depressive
and anxious symptoms, across a range of follow-up periods
[12–15]; b) onset and duration of episodes of major
depression [16–19]; and c) mediated the effects of other
risk factors on the onset of depression [20]. Rumination
and worry have also been found to predict future levels of
other disorders, including anxiety, eating disorders and
substance abuse [18]. Furthermore, experimental studies
provide evidence that rumination causally influences
negative mood and a range of cognitive processes [11],
including increased negative thinking [21], impaired
concentration [22] and impaired problem-solving [23].
This relationship between RNT and emotional disorders is
also found in children and adolescents [12, 18, 24–26].
Moreover, Hankin [27] demonstrated that rumination is a
specific risk factor for depression in adolescence, with ru-
mination prospectively predicting fluctuations in depres-
sive symptoms and internalising problems, but not anxious
arousal or externalising problems. A gender bias exists in
depression rates (approximately 2:1 female: male [28]).
Differences in rumination levels can partially explain this
gender bias, with 27 % of the association between gender
and depression explained by rumination [27]. Critically,
recent experimental and clinical studies have shown that
with brief interventions, levels of rumination and worry
can be reduced (e.g. [29–33]). This suggests that rumin-
ation/worry could be a particularly promising target in
improving the efficacy of preventive interventions.
Widespread dissemination and coverage of interventions
is important for effective prevention. Traditional face-to-
face therapy is not well-suited for such widespread imple-
mentation. Alternative modes of delivery, such as internet-
based treatments, have potential advantages including the
following: reaching large numbers at a relatively low cost;
greater ease of access and convenience for the user; avail-
able at any time and place; and greater autonomy for the
client, anonymity and greater time to reflect [6, 34, 35].
Emergent evidence exists that internet-based CBT is an
effective, feasible and acceptable treatment for acute
depression and anxiety [36, 37]. Acceptability ratings for
internet-based therapies are generally high [35]. However,
difficulties with motivation and adherence are a potentially
important issue for Internet-based therapies for depression.
Although purely self-guided internet interventions for
depression are available, they are generally less effective
and have greater drop-out than guided interventions for
depression with therapist input [36, 38, 39]. Andersson
[34] therefore argued for some form of guidance in order
to achieve similar effectiveness to face-to-face therapies.
The feasibility, acceptability, and efficacy of internet-
based rumination-focused CBT (i-RFCBT) to prevent
depression in adolescents and young adults has recently
been investigated in the Netherlands (Topper, Emmelkamp,
Watkins and Ehring: Prevention of anxiety disorders and
depression by targeting excessive worry and rumination in
adolescents and young adults; A randomized controlled
trial. Submitted; ZonMw funded project). The intervention
is based on rumination-focused cognitive behavioural ther-
apy (RFCBT) developed by Watkins et al. [30, 32]. Watkins
et al. [32] conducted a randomised-controlled trial compar-
ing treatment-as-usual (TAU, antidepressant medication)
versus TAU plus RFCBT in patients with medication-
refractory residual depression. The addition of RFCBT re-
duced depressive symptoms more than medication alone,
with improvements in remission rates (62 % vs. 21 %) and
reduction in 5-month relapse rates (9.5 % vs. 53 %) More-
over, changes in rumination scores were found to be a
significant mediator of these treatment effects. These posi-
tive treatment and relapse prevention results led Topper
et al. to adapt this intervention for prevention.
In a prevention trial of RFCBT, 251 students aged 15-22
with elevated worry and/or rumination (scoring on top
quartiles of respective measures: ≥ 50 on Penn State
Worry Questionnaire (PSWQ; [40]; ≥ 40 on Ruminative
Response Scale of the Response Styles Questionnaire
(RRS; [15])) but who did not currently meet diagnostic
criteria for depression or generalized anxiety disorder
were recruited, and randomised into face-to-face group
RFCBT, internet-delivered RFCBT (i-RFCBT), or a no-
intervention control group. Participants were assessed for
symptoms and ‘caseness’ of depression and anxiety on stan-
dardised self-report measures (Patient Health Question-
naire, PHQ-9; [41]; Generalized Anxiety Disorder Screener,
GAD-7; [42]) at baseline, post-intervention, 3 month and
12 month follow-ups. This study indicated the feasibility
of recruiting and retaining participants for such a pre-
vention study and indicated the acceptability of these
interventions. Further, group RFCBT and internet
RFCBT reduced worry, rumination, depression and
anxiety symptoms significantly more than waiting list
control. At 12 month follow-up, cumulative incidence
rates for depression (estimated from “caseness” on
PHQ-9) are reduced in the two RFCBT intervention
groups (13.1 %) relative to controls (32.2 %). More-
over, reductions in rumination and worry were found
to mediate the effects of RFCBT on symptom severity.
These findings are encouraging. However, there are
several key limitations of the Dutch study: (a) there is
not a diagnostic interview to determine incidence of
major depression, with the study instead using self-
report and only able to assess point prevalence rather
than retrospective incidence; (b) similarly, it is not
known whether the participants had previous episodes
of depression, i.e., whether the intervention prevents
first onset or relapse/recurrence of depression.
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Study aims and objectives
The primary aim of this phase III efficacy trial is to replicate
and extend the Dutch study to compare guided i-RFCBT
with a no-intervention control. If the target sample size
based on the comparison of guided i-RFCBT to controls in
the Dutch trial is achieved, the aim is to assess whether the
findings from this previous trial can be replicated in a differ-
ent population of undergraduates in the United Kingdom.
The RESPOND study will address the limitations of the
Dutch trial by including a well-validated diagnostic inter-
view (Structured Clinical Interview for DSM-IV (SCID-I
[43]) to increase accuracy in determining current and past
diagnostic status, and to allow for stratification on history
of depression. Although including previously depressed
participants is not consistent with strict definitions of initial
onset prevention studies, there is a strong argument for
preventing further relapses and recurrences, especially as a
major risk factor for a depressive episode is a history of
depressive episodes [6].
One key change from the design of the Dutch trial is the
selection of a young adult population aged 18-24-years,
principally undergraduates, rather than 15-22 years-old, in
order to recruit participants able to provide their own in-
formed consent. This age group was chosen for a number
of reasons: (a) for pragmatic reasons to improve feasibility
and logistics of recruitment, since parental consent can be
a barrier to recruitment for an internet-based prevention
study [44]; (b) larger effect sizes are found for older
adolescents in preventive studies, perhaps because older
adolescents are better able to understand the intervention
compared to younger adolescents or children [4] and c)
life transitions such as moving out of the family home
have been shown to increase the incidence of depression
[45]. Additionally depression is prevalent in this popula-
tion [46] and the number of students experiencing high
levels of worry, stress and symptoms of depression and
anxiety is also high [47], indicating that there is a signifi-
cant group of at-risk students who could be targeted with
a preventive intervention.
While previous research suggests guided interven-
tions are more efficacious than unguided interven-
tions, making the study of guided i-RFCBT our
primary goal, clinically relevant benefits could still be
obtained with unguided interventions as these have
the potential to be accessed by larger numbers at a
lower cost, and are essential for making highly scal-
able interventions. As a quasi-phase II pilot arm, we
will therefore also include an unguided version of i-
RFCBT to pilot its feasibility. This inclusion aims to
assess the feasibility of retention and acceptability of
the unguided intervention, as well as to estimate its
effect sizes and variability to aid planning for a fully
powered definitive trial of the unguided version, with
respect to rates of incidence and levels of symptoms
(descriptives and confidence intervals), as a separate
analysis from the primary Phase III design.
Methods/Design
Study Design
Phase III efficacy study
The phase III study will consist of a single (researcher)
blind parallel-group randomised-controlled trial (RCT),
comparing guided i-RFCBT versus a no-intervention
control group, with this our primary research question.
Quasi-Phase II pilot arm
A separate adjunct arm of unguided i-RFBCT will be
included as a quasi-phase II pilot arm to enable a feasi-
bility study of this intervention. This will be a separate
question, and there will be no direct comparison
between unguided i-RFCBT and the guided i-RFCBT or
control arms in the phase III efficacy study.
Setting
The study will be conducted over the internet and by tele-
phone so we will recruit from around the UK. The interven-
tion will be delivered on the internet, with the guided version
being supported by trained staff at the University of Exeter.
Participant inclusion criteria
Participants will be young adults resident in the UK aged
18 to 24 years and with elevated RNT, defined as scoring
above the 75th percentile on at least one measure of worry/
rumination (≥50 on the PSWQ [40] and/or ≥ 40 on the
RRS [15]). Additionally, participants must be able to under-
stand written English to engage with the intervention and
have private internet access to ensure confidentiality. In line
with standard practice, participants currently receiving anti-
depressant medication will be eligible, provided the dosage
has been stable for at least the previous month.
Participant exclusion criteria
Because this is a prevention study, participants will be
excluded if they meet diagnostic criteria for a current
(within past month) major depressive episode. Addition-
ally, potential participants will be excluded if they report
current and significant substance abuse or dependence;
current symptoms of psychosis or bipolar disorder;
current psychological therapy; or active suicide risk.
Recruitment procedure
The main recruitment pathway involves contacting
university departments around the UK by email and
asking them to circulate an advert to their undergradu-
ate students (as successfully used by Kingston et al.
[48]). Generic discipline email addresses, or named indi-
viduals within the departmental administration team
where possible, will be obtained using internet searches.
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Departments will be asked to circulate an included advert
in the form of an attached pdf, containing a hyperlink to an
online trial website that provides information and the initial
online screening measures, to undergraduates within their
department. The pdf format ensures departments can dis-
play the advert as a poster if they are not permitted to cir-
culate by email. The number of emails sent out each week
will be modulated depending on the response rates.
A Facebook and Twitter account will be set up to help cir-
culate the advert, particularly to non-students. Relevant orga-
nisations working with young people and/or mental health
issues will also be asked to advertise a link to the study on
their website.
Screening, baseline and consent procedure
Initial Online screening
An online screening website will be used to identify
potentially eligible participants. A brief introduction to
the study is included on the introductory page. Consent
to online screening is obtained by informing potential
participants that by clicking continue on this introduc-
tory page they are consenting for their responses to be
stored by the researchers and that this data is subject to
the Data Protection Act 1998.
A series of short questionnaires is then presented to
identify potentially eligible participants by collecting
basic demographic information (age, sex, ethnicity, loca-
tion, and how they learned of the study) and screening
on shortened versions of the PSWQ (four items, range 4
to 20, cut-off ≥ 12) and RRS (five items, range 5 to 20,
cut-off ≥ 10) as used by the Dutch trial to identify indi-
viduals with elevated RNT (that is, > 75th percentile)
and the PHQ-8 [49] (PHQ-9 minus the suicidal thought
question) to exclude participants who are likely to meet
a diagnosis for current depression (cut-off ≥ 15).
Automated feedback informs participants whether they
are eligible for further screening. Those excluded on low
worry/rumination are informed that worry and rumination
do not appear to be a significant problem for them and are
thanked for their interest. Those excluded on high PHQ
score are given a message explaining that their scores
indicate low mood which is affecting their quality of life
and that they may be experiencing an episode of clinical de-
pression. This message advises them to see their GP and
provides contact details of organisations offering support
and advice. Eligible participants are invited to leave their
contact details (name, telephone number and email ad-
dress) as consent to be contacted. The full information
sheet and consent form are then sent by email to the
participant with an invitation to participate in a telephone
interview with the researcher. The full information sheet
(Additional file 1) and consent form (Additional file 2) are
then sent by email to the participant with an invitation to
participate in a telephone interview with the researcher.
Telephone screening and baseline assessment
The researcher will provide the interviewee with an
overview of the trial, conduct the clinical interview and
ask for verbal consent. Interviews will be audio-recorded,
with the participant’s consent, so that the diagnostic status
can be independently rated. The screening interview
consists of brief screening questions on alcohol and
drug use; symptoms of bipolar disorder and psychosis
(Psychosis Screening Questionnaire, PSQ [50]); assess-
ment of any relevant past or current treatments; and
the Structured Clinical Interview for DSM-IV (SCID-I;
[43]) sections on current and past depressive episodes,
dysthymia and any relevant anxiety disorders and eating
disorders. As the primary objective of this study is to
investigate the prevention of depression, anxiety and
eating disorders will be measured, but participants
meeting the criteria for a disorder will not be excluded
from this study.
Excluded participants are given feedback including
advice to visit their GP and contact details of organisations
for further support. Additionally, any risk reported during
the interview is assessed using a well-established protocol
to ensure that appropriate clinical support is obtained.
Eligible participants are then asked to complete baseline
measures, assessing episodic stress (the Episodic Life
Event Interview, part of the UCLA Life Stress Interview
[51]); levels of worry and rumination (PSWQ and RRS);
symptom severity of depression and generalized anxiety
(PHQ-9 and GAD-7); neuroticism (Eysenck Personality
Questionnaire-Revised Neuroticism sub-scale (EPQ-R;
[52]) and history (family history of depression, experience
of abuse in childhood). With the exception of the episodic
stress interview, which is always completed during the
interview, baseline measures can be completed during the
telephone interview, or returned by email/post.
Consent to trial
All eligible participants will then be invited to enter the
trial and asked to return the written consent to partici-
pate. Once consent is received, the participant will be
randomised (see Fig. 1).
Randomisation and allocation concealment
Independent computer-generated block randomisation
to the guided i-RFCBT, unguided i-RFCBT or the no-
intervention control group will be used. Randomisation
will be stratified by sex and by past history of depression
(presence or absence of past depressive episodes) to
assess the effect of sex on outcomes and to examine
potential differences between prevention of first onset
and relapse prevention. The randomisation uses blocks
of three to ensure close parity of randomisation across
the intervention arms across time. Because of the two
levels of stratification by sex and by level of depression,
Cook and Watkins Trials  (2016) 17:1 Page 5 of 11
with blocks of three, the researcher would not be able to
anticipate or determine allocation easily, and the use of
varying block sizes was therefore deemed unnecessary.
In order to preserve blinding of the study researcher,
randomisation will be conducted by a third party not
involved in assessing or treating the participants, and
this third party will also inform the therapist, who will
be responsible for informing participants of their
allocation.
Sample size calculation for phase III efficacy trial
Power and sample size calculations were based on testing
the primary question of the efficacy of guided internet-
RFCBT in terms of reducing the onset of major
depression relative to the no-intervention control. For
our primary comparison of guided i-RFCBT versus
the no-intervention control, the Topper et al. study
using the binary outcome of number of individuals
meeting caseness for depression at 12 months, reported
Fig. 1 CONSORT diagram
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13.1 % incidence of depression in guided i-RFCBT and
32.2 % incidence in the no-intervention control (hazard
ratio = 0.41). Assuming similar effect sizes to the Topper
et al. study for our intended time-to-outcome survival
analysis over 12 months, then to detect the hazard ratio of
0.41 between these arms at the two-tailed 5 % alpha level,
75 participants must be recruited to each arm to provide
86 % power.
Estimates for change in depressive symptoms pre-to-
post intervention for the guided i-RFCBT relative to the
waiting list control indicate that 78 participants per arm
provide a power of 80 % to detect the observed effect
size of d = 0.51 from the Dutch trial at the two-tailed
5 % alpha level, allowing for the 20 % follow-up drop-
out attrition observed in the Dutch study.
Sample for quasi-phase II pilot arm
In the absence of any data on the unguided i-RFCBT, no
power and sample size calculation was conducted for
this arm. We will therefore aim to recruit the same
number of participants for this arm as the other arms
(n = 78), giving a total sample size of 234. The inclusion
of this intervention arm is to explore the feasibility of this
unguided intervention with respect to attrition, acceptabil-
ity and estimates of incident rate and effect size.
Interventions
Guided i-RFCBT
The guided intervention is an English version of i-RFCBT
(called MindReSolve). RFCBT is derived from theoretical
models [11] and experimental findings, which propose the
existence of distinct types of repetitive thought (RT) with
distinct consequences: constructive RT is characterized by
a concrete, specific and action-oriented mode of process-
ing, focusing on how events happen, whereas uncon-
structive RT is characterised by an abstract and evaluative
processing mode, focusing on the meaning and implica-
tions of events and difficulties [11]. In experimental
studies, relative to the abstract mode, the concrete mode
improved problem-solving [53, 54] and reduced emotional
reactivity in response to failure [55]. Underpinning
RFCBT is the idea that shifting individuals into the
concrete mode will reduce unconstructive rumination;
consistent with this, repeated training of dysphoric and
depressed participants to become more concrete reduces
depression and rumination in both a proof-of-principle
study and a randomised controlled trial [31, 33]. RFCBT
therefore involves experiential and imagery exercises to
adaptively shift processing mode (including concreteness,
absorption and compassion), as well as functional analysis
to help patients spot when rumination starts, distinguish
between helpful versus unhelpful RT, and learn more
functional responses. RFCBT seeks to change the process
of thinking as opposed to the content of thoughts as in
standard CBT [30]. In addition, rumination is conceptua-
lised as a form of avoidance [11, 56], which is targeted on
behavioural activation principles [57] with avoidance
behaviour being replaced with more appropriate approach
behaviours.
I-RFCBT consists of six modules, each taking around
an hour to complete in session and 1 to 2 weeks to prac-
tise. It includes psycho-education, mood diaries, on-line
experiential exercises using audio-recordings, pictures
and video vignettes of students’ experiences of the ther-
apy. The modules each follow the same basic structure:
reflection on the previous session, introduction of a new
technique, practical exercises and planning how to prac-
tise or implement the technique in daily life. The specific
behaviour-change techniques are drawn from the follow-
ing groups in the BCT Taxonomy (v1) [58]: goals and
planning (goal setting, action planning, review behaviour
and behavioural contract), feedback and monitoring
(self-monitoring of behaviour and outcomes), shaping
knowledge (information about antecedents), natural con-
sequences (information about social and environmental
consequences and monitoring of emotional conse-
quences), associations (prompts/cues and associative
learning), repetition and substitution (behavioural
practice/rehearsal, behaviour substitution, and habit
formation), antecedents (restructuring physical and
social environment, avoiding/reducing cues for the behav-
iour), and self-belief (mental rehearsal of successful per-
formance, focus on past success, and self-talk). The key
strategies include coaching participants to spot warning
signs for rumination and worry, and then to make IF-
THEN plans in which an alternative strategy is repeatedly
practised in response to the warning signs. These strat-
egies include being more active, slowing things down,
breaking tasks down, opposite action, relaxation, concrete
thinking, becoming absorbed, self-compassion and
assertiveness.
The intervention is accessed through a secure website,
with each participant having a password protected
account. Participants’ log-ins are automatically recorded
by the programme, allowing for an automated measure
of treatment compliance. Reminder emails will be sent
to participants after 2 weeks if they have not completed
the module.
The participant can work through each module at his
own pace but can only move from one module to the
next after the coach has provided feedback. The coach
will provide feedback on these responses within 2 working
days, in particular highlighting any positive steps made
and encouraging participants to sustain these as well as
pointing out areas to focus on over the next module.
Participants will also be able to send questions to their
assigned therapist throughout the programme if they are
having difficulty with a specific exercise.
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The intervention will be supported by qualified clinicians
who have received specific training in the rumination-
focused CBT approach. Treatment fidelity is ensured
through the use of fixed modules in the platform, ensuring
that all participants receive identical content. Detailed tem-
plate responses for each module provide the coach with
constrained feedback faithful with the treatment model,
which they can then tailor to individual client responses.
All responses from both the client and coach are automat-
ically saved by the online platform, and a random sample
will be checked against the templates to ensure they are
faithful to the treatment. Furthermore, coaches will be
provided with ongoing supervision with the developer of
RFCBT to encourage fidelity. Supervision meetings will
involve a brief overview of all clients and a more in-depth
discussion of cases deemed to be more complex or where
there is risk or non-response to the intervention.
Unguided i-RFCBT
The unguided version of the therapy contains the same
six modules as the guided version, with almost identical
content, adapted for self-help, including some condi-
tional feedback on common difficulties with exercises.
Participants are able to move freely from one module to
the next, but are advised to spend 1 to 2 weeks on each
to allow time for practice. Participants in the unguided
version will be made aware that there is no coach moni-
toring their responses. However, they will be told that
their questionnaire scores will be monitored on a weekly
basis to check for any risk reported.
Control condition
Participants in the control condition will be informed
that they have been allocated to carry on as usual. In
order to ensure participants’ welfare, participants are
permitted to access any other treatments throughout the
course of the study, as necessary. They will also be able
to access the unguided i-RFCBT at the end of the study
if they so wish.
Blinding
This is a single blind study, with the researcher conducting
outcome measures while blind to allocation. Participants
will be asked at the end of the screening interview not to
disclose their allocation to the researcher in any of their
future correspondence with the researcher and reminded
of the importance of this prior to and during each follow-
up interview. Due to the intervention, participants and
therapists cannot be blinded.
Follow-up assessments and outcome measures
The primary outcome of interest of this study is the onset
of a major depressive episode over a 12-month period,
which we will assess with the SCID-I at 3 (post-
intervention), 6 and 15 months after randomisation. The
use of the SCID-I will allow for the ascertainment of
depressive episodes that may have occurred between
assessments (continuous time-to-onset and occurrence)
and will also enable us to assess clinically significant
symptoms of anxiety (particularly generalized anxiety dis-
order) that may have arisen in isolation or comorbid with
depression. The severity of the depressive symptoms is
measured using the PHQ-9 and of the anxiety symptoms
using the GAD-7. The effect of the intervention on levels
of worry and rumination will be assessed using the PSWQ
and RRS. A number of potential confounding variables are
also measured: stressful life events, using the Episodic Life
Event Interview and any treatments received outside the
trial (medication, therapy and use of self-help materials).
Each assessment will take place via a telephone interview,
with the option of the questionnaire measures being
returned by email or post. To increase participant reten-
tion and completion of follow-ups, multiple attempts and
multiple means (email, telephone and post) will be used to
contact participants. Additionally, to increase motivation
to complete the follow-up measures, lottery draws for £50
in vouchers will be held, with each participant receiving
one ticket per completed follow-up.
Feasibility and acceptability outcome measures
(quasi-phase II pilot arm)
With respect to the unguided intervention, feasibility and
acceptability of data collection procedures, levels of attri-
tion, effect size and acceptability of the unguided internet
RFCBT intervention will be measured to aid planning for
a fully powered, definitive, phase III trial. The feasibility of
data collection procedures will be assessed by measuring
the missing items on the clinical outcome measures, the
number and timing of drop-outs and whether these vary
across arms. The acceptability of the intervention will be
assessed using a behavioural index, which will measure
the number of modules completed, the time spent logged
into the site and which modules are completed more
easily or frequently than others.
Statistical analysis plan for phase III efficacy trial
Data cleaning will follow the protocol set out by
Tabachnick and Fidell [59]. Statistical analysis will follow
the CONSORT standards [60]. Unplanned missing data
will be handled via multiple imputation (MI). Sensitivity
analysis, assuming a variety of MI models (Missing at
Random; Missing Not at Random), will verify the likely
impact of missing data. Auxiliary variables will be used to
improve the estimation of missing data. Primary analyses
will be conducted on the intention-to-treat (ITT) sample.
Subsequent analyses will use the Complier Average
Causal Effect (CACE) analysis [61, 62]. CACE assumes
that randomisation has no direct effect on outcome
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variable; instead it assumes that the effect of treatment
depends on the compliance to treatment (operational-
ized in terms of completing four out of six modules),
which in turn is dependent on randomisation. Therefore,
CACE provides estimates of a treatment effect whilst
taking into account adherence and compliance with the
treatment and whilst also retaining the benefits of
randomisation. This model is thus an exemplar of using
an Instrumental Variable (IV) where randomisation is
the instrument, which is correlated with compliance to
the treatment, and directly unrelated to the outcome. In
simple terms, CACE finds the difference in the outcome
variable between the compliers in the treatment arm
and the compliers in the control arm had they been
offered the treatment, assuming that the rates of compli-
ance are similar in both arms as a consequence of
randomisation.
As a prevention study, the main outcome of interest
is the occurrence and time to onset of any depressive
episode. Cox regression survival analyses will be
performed to examine the effect of the preventive
intervention on episode onsets of major depression.
Participants will be censored upon measurement
dropout or end of study. Although condition will be
the main independent variable included in the model,
we will also consider sex and history of past depres-
sion (the stratification variables).
The secondary outcome of occurrence/time to onset of
generalized anxiety disorder will also be assessed using
Cox regression survival analyses. Symptom severity and
levels of rumination/worry will be examined using mixed
model ANCOVAs: between group (ITT/CACE) and
repeated measures (3 to 15-month follow-ups), with
baseline symptom levels and stratification variables as
covariates.
Mediation and moderation analysis
Mediational analyses will be used to test the hypothesis
that rumination acts as mediator of the treatment effects
of condition on onset of major depression using the
approach outlined by Kraemer et al. [63]. Potential
moderators (for example, stratification variables and
baseline characteristics) will also be investigated using
this approach.
Ethical approval
Ethical and professional guidelines will be followed at all
times, in line with Good Clinical Practice guidelines.
Ethical approval has been obtained from the Ethics
Committee of the School of Psychology, University of
Exeter (Ref: 2012/554). Any possible adverse events
witnessed by the researcher or the therapist will be
discussed as soon as possible with the supervisor. If this
is deemed to be an adverse event, an adverse event
report will be completed. In the case of serious adverse
events, the University of Exeter, as sponsor, will also be
notified using the same report and a follow-up phone call.
Discussion
The current trial has been designed to build on the find-
ings from the ZonMw trial, assessing the efficacy of guided
i-RFCBT in a UK-based young adult population relative to
a no-intervention control in the prevention of depression.
Critically, to overcome the limitations of this study,
diagnostic interviews at each assessment point will allow
for more accurate measures of incidence rates across the
course of the follow-up period.
I-RFCBT may provide an effective and acceptable inter-
vention for the prevention of depression in young adults.
Widespread implementation is a key factor in prevention
and the internet may provide a valuable tool in increasing
access. Furthermore, while previous evidence suggests
guided therapy will be more efficacious, the assessment of
an unguided version allows a preliminary investigation of
the potential benefits of increased availability and reduced
cost that this may provide.
Trial status
Recruitment began in November 2013 and was ongoing
at the time of submission.
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